Use of an antibody that inhibits pd-1 activity for the preparation of a medicament for alleviating or preventing a symptom of persistent viral infection, angioimmunoblastic lymphoma or nodular lymphocyte predominant hodgkin lymphoma
Номер патента: IL187999A
Опубликовано: 26-02-2015
Автор(ы):
Принадлежит: Brigham & Womens Hospital, Dana Farber Cancer Inst Inc, Harvard College, Univ Emory
Опубликовано: 26-02-2015
Автор(ы):
Принадлежит: Brigham & Womens Hospital, Dana Farber Cancer Inst Inc, Harvard College, Univ Emory
Method for the diagnosis and treatment of cardiovascular diseases
Номер патента: US20090239218A1. Автор: Matthias Herrmann,Detlef Kozian,Thomas Leeuw,Winfried Maerz,Wilfried Renner. Владелец: Sanofi Aventis France. Дата публикации: 2009-09-24.